Global Transdermal Skin Patches Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025

  • ID: 4431637
  • Report
  • Region: Global
  • Acute Market Reports
1 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • AdhexPharma
  • Allergan plc
  • Medherant Limited
  • Medipatch, Inc.
  • NITTO DENKO CORPORATION
  • MORE

The market is expected to expand at a CAGR of 4.2% from 2017 to 2025.

Market Insights

Transdermal drug delivery has been an attractive and challenging area of research. Advances in modern technologies are resulting in a larger number of drugs being delivered transdermally including conventional hydrophobic small molecule drugs, hydrophilic drugs and macromolecules. Transdermal delivery provides convenient and pain-free self-administration of drugs as leading to patient compliance especially in the chronic condition where long term treatment is necessary. Patches are presently being marketed which can be worn anywhere from as little as eight hours to as long as seven days, depending on their therapeutic indication. Based on the type of product type, the transdermal skin patches market is categorized into matrix, drug in adhesive, reservoir and vapor. The matrix segment held the largest share in the overall transdermal skin patches market due to product modification in terms of controlled release setting. Moreover, non-toxic and non-antagonistic characteristics of polymer matrix options, which are known to diffuse drug with controlled precision would further drive the market in the future. On the basis of application the transdermal skin patches are segmented into pain relief, nicotine cessation, hormone replacement therapy, motion sickness, neurological disorders, cardiovascular disorders, and others. Transdermal patches for pain relief is the major contributing market as they are preferred over hypodermic injections, which are more painful, generate medical waste, and pose a risk of disease transmission. Improved patient compliance as the treatment is non-invasive, simple, and convenient, and there is greater flexibility in termination of drugs by the removal of patches.

Geographically, North America dominated the global medical foods market which was followed by Europe. The key market drivers assisting in the growth of North America transdermal skin patches comprises rise in research and development in non-invasive methods of treatment for chronic conditions such as pain relief, motion sickness and other lifestyle related disorders. Moreover, the developed countries like U.S. U.K and others in North America and Europe, the adoption rate of the non-invasive and novel treatment is more than the developing nations. However, Asia Pacific has emerged as the fastest growing region in the transdermal skin patches market due to rising demand for better treatment at affordable cost in the region. Furthermore, innovation and government funding in the development of cutting-edge technology and healthcare infrastructure would augment the growth of Asia Pacific transdermal skin patches market.

Market Competition Assessment

The transdermal skin patches market currently have comprises number of companies marketing their products in the market. The major players in the transdermal skin patches market include: Teva Pharmaceutical Industries Ltd., Mylan Pharmaceuticals Inc, 3M Company, Accrux Ltd., Access Pharmaceuticals Inc., and others.

READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • AdhexPharma
  • Allergan plc
  • Medherant Limited
  • Medipatch, Inc.
  • NITTO DENKO CORPORATION
  • MORE
Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I - Secondary Research
1.3.2 Phase II - Primary Research
1.3.3 Phase III - Expert Panel Review
1.3.4 Assumptions

Chapter 2 Executive Summary
2.1 Transdermal Skin Patches Market Portraiture
2.2 Transdermal Skin Patches Market, by Product Type, 2016 (US$ Mn)
2.3 Transdermal Skin Patches Market, by Application Type, 2016 (US$ Mn)
2.4 Transdermal Skin Patches Market, by Geography, 2016 (Value %)

Chapter 3 Global Transdermal Skin Patches Market Analysis
3.1 Global Transdermal Skin Patches Market Overview
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.2 Challenges
3.2.3 Opportunities
3.3 Mergers, Acquisition and Business Strategies
3.4 Porter’s Analysis
3.5 Attractive Investment Proposition
3.6 Competitive Analysis: Global Transdermal Skin Patches Market, 2016 (Value %)

Chapter 4 Global Transdermal Skin Patches Market Analysis, By Product Type
4.1 Overview
4.1.1 Market Attractive Proposition of Transdermal Skin Patches Market, by Product Type, 2016
4.1.2 Top 3 Countries
4.2 Matrix
4.3 Drug in Adhesive
4.4 Reservoir
4.5 Multilaminate

Chapter 5 Global Transdermal Skin Patches Market Analysis, By Application Type
5.1 Overview
5.1.1 Market Attractive Proposition of Transdermal Skin Patches Market, by Application Type, 2016
5.1.2 Top 3 Countries, By Application Type (US$ Mn), 2015- 2025 (Value)
5.2 Pain Relief
5.3 Nicotine Cessation
5.4 Hormone Replacement Therapy
5.5 Motion Sickness
5.6 Neurological Disorder
5.7 Cardiovascular Disorder
5.8 Others

Chapter 6 Global Transdermal Skin Patches Market, By Geography
6.1 Preface
6.2 North America (U.S. & Canada)
6.2.1 North America Transdermal Skin Patches Market, by Product Type, 2015-2025 (US$ Mn)
6.2.2 North America Transdermal Skin Patches Market, by Application Type, 2015-2025 (US$ Mn)
6.2.3 North America Transdermal Skin Patches Market, by Country, 2015 - 2025 (US$ Mn)
6.3 Europe (U.K., Germany & Rest of Europe)
6.3.1 Europe Transdermal Skin Patches Market, by Product Type, 2015-2025 (US$ Mn)
6.3.2 Europe Transdermal Skin Patches Market, by Application Type, 2015-2025 (US$ Mn)
6.3.3 Europe Transdermal Skin Patches Market, by Country, 2015 - 2025 (US$ Mn)
6.4 Asia-Pacific (China, Japan & Rest of Asia-Pacific)
6.4.1 Asia Pacific Transdermal Skin Patches Market, by Product Type, 2015-2025 (US$ Mn)
6.4.2 Asia Pacific Transdermal Skin Patches Market, by Application Type, 2015- 2025 (US$ Mn)
6.4.3 Asia - Pacific Transdermal Skin Patches Market, by Country, 2015 - 2025 (US$ Mn)
6.5 Latin America (Brazil, Mexico and Rest of LATAM)
6.5.1 Latin America Transdermal Skin Patches Market, by Product Type, 2015- 2025 (US$ Mn)
6.5.2 Latin America Transdermal Skin Patches Market, by Application Type, 2015-2025 (US$ Mn)
6.5.3 Latin America Transdermal Skin Patches Market, by Country, 2015 - 2025 (US$ Mn)
6.6 Middle East and Africa
6.6.1 Middle East and Africa Transdermal Skin Patches Market, by Product Type, 2015-2025 (US$ Mn)
6.6.2 Middle East and Africa Transdermal Skin Patches Market, by Application Type, 2015-2025 (US$ Mn)
6.6.3 Middle East and Africa Transdermal Skin Patches Market, by Country, 2015 - 2025 (US$ Mn)

Chapter 7 Company Profiles
7.1 Abbott Laboratories
7.2 ProSolus, Inc.
7.3 Medipatch, Inc,
7.4 AdhexPharma
7.5 Aneva Drug Delivery Systems
7.6 Medherant Limited
7.7 Allergan plc
7.8 NITTO DENKO CORPORATION
7.9 Mylan Pharmaceutical, Inc.
7.10 Corium International, Inc.
7.11 Noven Pharmaceuticals, Inc.
7.12 Teva Pharmaceuticals, Inc.
7.13 Johnson & Johnson, Inc.
7.14 Access Pharmaceuticals Inc.

List of Figures
Fig. 1 Transdermal Skin Patches Market: Research Methodology
Fig. 2 Transdermal Skin Patches Market, by Product Type, 2016 (US$ Mn)
Fig. 3 Transdermal Skin Patches Market, by Application Type, 2016 (US$ Mn)
Fig. 4 Transdermal Skin Patches Market, by Geography, 2016 (Value %)
Fig. 5 Attractive Investment Proposition
Fig. 6 Competitive Analysis: Global Transdermal Skin Patches Market, 2016 (Value %)
Fig. 7 Global Matrix Market(US$ Mn), 2015-2025
Fig. 8 Global Drug in Adhesive Market(US$ Mn), 2015-2025
Fig. 9 Global Reservoir Market (US$ Mn), 2015-2025
Fig. 10 Global Multilaminate Market (US$ Mn), 2015-2025
Fig. 11 Global Pain Relief Market(US$ Mn), 2015-2025
Fig. 12 Global Nicotine Cessation Market(US$ Mn), 2015-2025
Fig. 13 Global Hormone Replacement Therapy Market (US$ Mn), 2015-2025
Fig. 14 Global Motion Sickness Market (US$ Mn), 2015-2025
Fig. 15 Global Neurological Disorder Market (US$ Mn), 2015-2025
Fig. 16 Global Cardiovascular Disorder Market(US$ Mn), 2015-2025
Fig. 17 Global Others Applications Market(US$ Mn), 2015-2025

List of Tables
Table 1 Top 3 Countries, By Product Type (US$ Mn), 2015- 2025 (Value)
Table 2 Global Transdermal Skin Patches Market, By Product Type (US$ Mn), 2015- 2025 (Value)
Table 3 Top 3 Countries, By Application Type (US$ Mn), 2015- 2025 (Value)
Table 4 Global Transdermal Skin Patches Market, By Application Type (US$ Mn), 2015- 2025 (Value)
Table 5 Global Transdermal Skin Patches Market, by Geography, 2015 - 2025 (US$ Mn) Credence Research, Inc.
Table 6 North America Transdermal Skin Patches Market, by Product Type, 2015 - 2025 (US$ Mn)
Table 7 North America Transdermal Skin Patches Market, by Application Type, 2015 - 2025 (US$ Mn)
Table 8 North America Transdermal Skin Patches Market, by Country, 2015 - 2025 (US$ Mn)
Table 9 Europe Transdermal Skin Patches Market, by Product Type, 2015 - 2025 (US$ Mn)
Table 10 Europe Transdermal Skin Patches Market, by Application Type, 2015 - 2025 (US$ Mn)
Table 11 Europe Transdermal Skin Patches Market, by Country, 2015 - 2025 (US$ Mn)
Table 12 Asia Pacific Transdermal Skin Patches Market, by Product Type, 2015 - 2025 (US$ Mn)
Table 13 Asia Pacific Transdermal Skin Patches Market, by Application Type, 2015 - 2025 (US$ Mn)
Table 14 Asia - Pacific Transdermal Skin Patches Market, by Country, 2015 - 2025 (US$ Mn)
Table 15 Latin America Transdermal Skin Patches Market, by Product Type, 2015 - 2025 (US$ Mn)
Table 16 Latin America Transdermal Skin Patches Market, by Application Type, 2015 - 2025 (US$ Mn)
Table 17 Latin America Transdermal Skin Patches Market, by Country, 2015 - 2025 (US$ Mn)
Table 18 Middle East and Africa Transdermal Skin Patches Market, by Product Type, 2015 - 2025 (US$ Mn)
Table 19 Middle East and Africa Transdermal Skin Patches Market, by Applications Type, 2015 - 2025 (US$ Mn)
Table 20 Middle East and Africa Transdermal Skin Patches Market, by Country, 2015 - 2025 (US$ Mn)
Table 21 Abbott Laboratories: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
Table 22 ProSolus, Inc.: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
Table 23 Medipatch, Inc,: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
Table 24 AdhexPharma: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
Table 25 Aneva Drug Delivery Systems: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage) Credence Research, Inc.
Table 26 Medherant Limited: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
Table 27 Allergan plc: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
Table 28 NITTO DENKO CORPORATION: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
Table 29 Mylan Pharmaceutical, Inc.: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
Table 30 Corium International, Inc.: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
Table 31 Noven Pharmaceuticals, Inc.: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
Table 32 Teva Pharmaceuticals, Inc.: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
Table 33 Johnson & Johnson, Inc.: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
Table 34 Access Pharmaceuticals Inc.: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott Laboratories
  • ProSolus, Inc.
  • Medipatch, Inc.
  • AdhexPharma
  • Aneva Drug Delivery Systems
  • Medherant Limited
  • Allergan plc
  • NITTO DENKO CORPORATION
  • Mylan Pharmaceutical, Inc.
  • Corium International, Inc.
  • Noven Pharmaceuticals,
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll